Healthcare Equipment and Supplies
Company Overview of OrbusNeich Medical Company Limited
OrbusNeich Medical Company Limited designs, develops, manufactures, and markets medical devices for the treatment of vascular diseases. The company offers dual therapy, bare metal, pro-healing, bio-engineered R, and bio-engineered cobalt chromium stents; and other stents and balloons. It serves interventional cardiologists and physicians in Hong Kong and internationally through its predecessor companies, sales teams, and a distributor network. The company was formerly known as Neich Medical Company Limited and changed its name to OrbusNeich Medical Company Limited following its merger with Orbus Medical Technologies, Inc. in January 2005. The company was founded in 1979 and is headquartered ...
39 Gloucester Road
Founded in 1979
Key Executives for OrbusNeich Medical Company Limited
Chairman of The Board and Executive in Charge of Asia Pacific
Vice President of Sales and Marketing of EMEA and Director
Compensation as of Fiscal Year 2014.
OrbusNeich Medical Company Limited Key Developments
OrbusNeich Appoints B. Wayne Johnson as President and Chief Executive Officer
Aug 19 14
OrbusNeich announced the appointment of B. Wayne Johnson as president and chief executive officer (CEO), with responsibility for all commercial and clinical aspects of the company. Mr. Johnson, who has more than 32 years of medical device experience, will continue placing a heavy emphasis on research and development, cementing OrbusNeich's reputation as an innovative, forward-looking leader in interventional cardiology. Johnson joined OrbusNeich in 2002 and most recently has served in the role of president and chief operating officer.
OrbusNeich Announces Executive Changes
Apr 24 14
OrbusNeich announced the appointment of B. Wayne Johnson as president and chief operating officer and the expansion of its board of directors with the additions of Scott Addonizio, vice president & general manager, Shenzhen operations; David Camp, vice president, sales & marketing, Europe, the Middle East and Africa (EMEA); and Christophe Lee, vice president and chief financial officer. Mr. Johnson has more than 32 years of medical device experience, primarily in the areas of general management, operations and product development. He was previously senior vice president and chief operating officer of OrbusNeich.
OrbusNeich Launches New Coronary Dilatation Catheter
Apr 11 14
OrbusNeich has launched Sapphire II NC coronary dilatation catheter, a non-compliant balloon catheter to cross tight lesions. Sapphire II NC's proprietary balloon processing results in crossing profile for primary and repeated lesion entry. The enhanced distal Z-Tip with advanced laser welding technology results in ZERO transition between the distal tip and conventional steerable guidewires. Sapphire II NC is available in a broad range of sizes, from 1.75 mm to 5 mm, with a catheter working length of 140 cm.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|